Embedded Files
AcusMu is a specialized Medtech company on transdermal delivery for diabetic patients.
AcusMu is a specialized Medtech company on transdermal delivery for diabetic patients.
Fundraising Status
Fundraising Status
Seed Round
Fundraising Target: 10M
Schedule: Q4 2023
Revenue (USD)
Revenue (USD)
2022: 0
2023 Target: 30K
Competitors
Competitors
Corium (US)
SkinJect (US)
Nissha Group (Japan)
Raphas (Korea)
Wincoatco (TW)
US Objective
US Objective
Expected Results
Expected Results
Sale
Fundraising
Co-development partners
Specific Organizations/VCs to Engage
Specific Organizations/VCs to Engage
Biosimilar companies
Company Details
Company Details
Short description
Short description
AcusMu (Acus: Needle, Mu:Micro in Latin), was founded in May 2022. It is a specialized MedTech company, focused on transdermal drug delivery system. The company has obtained patents for its priority platform FMD(TM) for cosmetic and therapeutic dissolvable microneedle array patches. With its scale-up manufacture facility in Taiwan, we can provide high-quality products to our clients.
Core Technology
Core Technology
FMD(TM) for cosmetic and therapeutic dissolvable microneedle array patches.
Team Members
Team Members
You can meet her in person:
04/27-28 Maryland Spinoff
5/1-3 SelectUSA Summit (Maryland)
5/5-8 TAcc+ Silicon Valley Spinoff
Media Exposures
Media Exposures
Page updated
Report abuse